Is screening of Australian blood donors for HTLV-I necessary?

Medical Journal of Australia

Volumn 166, Issue 9, 1997, Pages 478-481

  Whyte, Gordon S ^a,b  

^a Australian Red Cross   (Australia)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; BLOOD BANK; BLOOD DONOR; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; RISK; RISK FACTOR; SCREENING; SEROCONVERSION; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0030954181     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1997.tb123220.x     Document Type: Article

References (28)

1. Doherty RR. HTLV-I in Australia and Oceania: long term resident or recent immigrant? Med J Aust 1996; 164: 84-86.
2. Gallo RC. A surprising advance in the treatment of viral leukemia. N Engl J Med 1995; 332: 1783-1784.
3. Ascher D, Goudsmit J, Poeroy K, et al. Antibodies to HTLV-I in populations of the south western Pacific. J Med Virol 1988; 26: 339-351.
4. Bastian I, Hinuma Y Doherty RR. HTLV-I among Northern Territory Aborigines. Med J Aust 1993; 159: 12-16.
5. Bastian I, Gardner J, Webb D, Gardner I. Isolation of a human T-lymphotropic virus type I strain from Australian Aboriginals. J Virol 1993; 67: 843-851.
6. Bastian I, Dent J, McFarlane R, et al. HTLV-I among Northern Territory blood donors. Med J Aust 1993; 159:7-12.
7. Hinuma Y. Natural history of the retrovirus associated with a human leukemia. Bioessays 1985; 3: 205-209.
8. Poeisz B, Ruscetti F, Gazdar A, et al. Detection and isolation of type C retrovirus particle from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415-7419.
9. Hollsberg P, Hafler DA. Pathogenesis of diseases induced by human lymphtropic virus type 1 infection. N Engl J Med 1993; 328: 1173-1182.
10. Nakano S, Ando Y, Saito K, et al. Primary infection of Japanese infants with adult T-cell leukemia associated retrovirus (ATLV): evidence for viral transmission from mothers to children. J Infect 1986; 12: 205-212.
11. May JT, Stent G, Schnagl RD. Antibody to human T-cell lymphotropic virus type I in Australian Aborigines [letter], Med J Aust 1988; 149: 104.
12. Barnes D, HTLV-I: to test or not to test. Science 1988; 242: 372-373.
13. Parkman PD. HTLV-I antibody testing; instruction of all registered blood establishments. Bethesda: Food and Drug Administration, 1988.
14. Public Health Service Working Group. Licensure of screening tests for antibody to human lympotropic virus type I. MMWR Morb Mortal Wkly Rep 1988; 37: 736-747.
15. Anon. Blood tests would drain funds: medics. Courier Mail 1992 June 5: 15.
16. National Health and Medical Research Council, Communicable Diseases Standing Committee. HTLV-I screening: outcome of consideration by the Executive. Canberra: NHMRC, 4 December 1992.
17. National Health and Medical Research Council. Case study of screening blood donations for human T-cell lymphotropic virus type I: Report of the Australian Health Ethics Committee. Canberra: NHMRC, November 1993.
18. Donegan E, Lee H, Operskalski GM, et al. Transfusion transmission of retroviruses: human T-lymphotropic virus type I and II compared with human immunodeficiency virus type I. Transfusion 1994; 34: 478-483.
19. PagliucaA, Pawson R, Mufti GJ. HTLV-I screening in Britain. BMJ 1995; 311: 1313-1314.
20. Kaplan JE, Litchfield B, Rouait C, et al. HTLV-I associated myelopathy associated with blood transfusion in the United States. Neurology 1991, 41: 192-197.
21. Sugiyama H, Doi H, Yamaguchi K, et al. Significance of post-natal mother-to-child transmission of human T-lymphotropic virus type-1 on the development of adult T-cell leukemia/lymphoma J Med Virol 1986; 20: 253-260.
22. Vrielink H, van der Poel CL, Reesink HW. Efficacy of selected versus random blood donor screening for anti HTLV-I antibodies [letter]. Vox Sang 1995; 68: 251-252.
23. Courouce AM, Pillonel J. Transfusion-transmitted viral infections. N Engl J Med 1996; 335: 1609-1610.
24. Schreiber GB, Busch MR Kleiman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996; 334: 1685-1690.
25. Whyte GS, Savoia HF. The effectiveness of donor selection for reducing the risk of HCV, HBV and HIV in new blood donors in Victoria. Med J Aust. In press.
26. Wylie B. HTLV-I: is donor screening really necessary? [editorial] Med J Aust 1993; 159: 4-5.
27. McGuire A, Henderson J, Mooney G. The economics of health care. London: Routledge. 1994: 112.
28. Health Act 1958 (Vic.), s. 139. Melbourne: The Law Printer, 1995.